Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice

Arthritis and Rheumatism

Volumn 52, Issue 2, 2005, Pages 651-658

  Dong, Li ^a   Ito, Shuichi ^a   Ishii, Ken J ^a   Klinman, Dennis M ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 12; OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLOMERULONEPHRITIS; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SURVIVAL RATE; SURVIVAL TIME;

ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; CYTOKINES; DISEASE PROGRESSION; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; INTERFERON TYPE II; INTERLEUKIN-12; KIDNEY; MICE; MICE, INBRED NZB; OLIGONUCLEOTIDES; PROTEINURIA;

EID: 13444302229     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20810     Document Type: Article

References (49)

1. Kotzin BL. Systemic lupus erythematosus. Cell 1996;85:303-6.
2. Klinman DM, Steinberg AD. Inquiry into murine and human lupus. Immunol Rev 1995;144:157-93.
3. Hahn BH. Antibodies to DNA. N Engl J Med 1998;338:1359-68.
4. Lambert PH, Dixon FJ. Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med 1968;127:507-13.
5. Theofilopoulos AN, Dixon FJ. Murine models of SLE. Adv Immunol 1985;37:269-85.
6. Steinberg AD, Klinman DM. Pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am 1988;14:25-41.
7. Ando DG, Sercarz EE, Hahn BH. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J Immunol 1987;138:3185-90.
8. Kuroiwa T, Lee EG. Cellular interactions in the pathogenesis of lupus nephritis: the role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus 1998;7:597-603.
9. Singh RR, Hahn BH, Tsao BP, Ebling FM. Evidence for multiple mechanisms of polyclonal T cell activation in murine lupus. J Clin Invest 1998;102:1841-9.
10. Trebeden-Negre H, Weill B, Fournier C, Batteux F. B cell apoptosis accelerates the onset of murine lupus. Eur J Immunol 2003;33:1603-12.
11. Pisetsky DS. Immune activation by bacterial DNA: a new genetic code. Immunity 1996;5:303-10.
12. Krieg AM. CpG DNA: a pathogenic factor in systemic lupus erythematosus? J Clin Immunol 1995;15:284-92.
13. Klinman DM, Zeuner R, Yamada H, Gursel M, Currie D, Gursel I. Regulation of CpG-induced immune activation by suppressive oligodeoxynucleotides. Ann N Y Acad Sci 2003;1002:112-23.
14. Krieg AM, Wu T, Weeratna R, Efler SM, Love-Homan L, Yang L, et al. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A 1998;95:12631-6.
15. Gursel I, Gursel M, Yamada H, Ishii KJ, Takeshita F, Klinman DM. Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J Immunol 2003;171:1393-400.
16. Zeuner RA, Ishii KJ, Lizak MJ, Gursel I, Yamada H, Klinman DM, et al. Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides. Arthritis Rheum 2002;46:2219-24.
17. Zeuner RA, Verthelyi D, Gursel M, Ishii KJ, Klinman DM. Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritis. Arthritis Rheum 2003;48:1701-7.
18. Dong L, Ito S, Ishii KJ, Klinman DM. Suppressive oligonucleotides protect against the development of collagen-induced arthritis in mice. Arthritis Rheum 2004;50:1686-9.
19. Ho PP, Fontoura P, Ruiz PJ, Steinman L, Garren H. An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems. J Immunol 2003;171:4920-6.
20. Klinman DM, Yi A, Beaucage SL, Conover J, Krieg AM. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFN-γ. Proc Natl Acad Sci U S A 1996;93:2879-83.
21. Wernick RM, Smith DL, Houghton DC, Phillips DS, Booth JL, Runckel DN, et al. Reliability of histologic scoring for lupus nephritis: a community-based evaluation. Ann Intern Med 1993;119:805-11.
22. Hasegawa K, Hayashi T. Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice. Lupus 2003;12:838-45.
23. 1 mice. J Immunol 1998;161:7023-30.
24. Trouw LA, Seelen MA, Duijs JM, Benediktsson H, van Kooten C, Daha MR. Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies. Clin Exp Immunol 2003;132:32-9.
25. Tsao BP, Ebling FM, Roman C, Panosian-Sahakian N, Calame K, Hahn BH. Structural characteristics of the variable regions of Ig genes encoding a pathogenic autoantibody in murine lupus. J Clin Invest 1990;85:530-40.
26. Dean GS, Tyrrell-Price J, Crawley E, Isenberg DA. Cytokines and systemic lupus erythematosus. Ann Rheum Dis 2000;59:243-51.
27. Brennan D, Yui M, Wuthrich R, Kelley V. Tumor necrosis factor and IL-1 in New Zealand black/white mice. J Immunol 1989;143:3470-5.
28. Seery JP, Carroll JM, Cattell V, Watt FM. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon γ in the epidermis. J Exp Med 1997;186:1451-9.
29. 1 mice. J Immunol 1998;160:3713-8.
30. Lenert P, Stunz L, Yi AK, Krieg AM, Ashman RF. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-κB activation. Antisense Nucleic Acid Drug Dev 2001;11:247-56.
31. Yamada H, Gursel I, Takeshita F, Conover J, Ishii KJ, Gursel M, et al. Effect of suppressive DNA on CpG-induced immune activation. J Immunol 2002;169:5590-4.
32. Stacey KJ, Young GR, Clark F, Sester DP, Roberts TL, Naik S, et al. The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J Immunol 2003;170:3614-20.
33. Pisetsky DS, Reich CF. Inhibition of murine macrophage IL-12 production by natural and synthetic DNA. Clin Immunol 2000;96:198-204.
34. Zhu FG, Reich CF, Pisetsky DS. Inhibition of murine macrophage nitric oxide production by synthetic oligonucleotides. J Leukoc Biol 2002;71:686-94.
35. Zhu FG, Reich CF, Pisetsky DS. Inhibition of murine dendritic cell activation by synthetic phosphorothioate oligodeoxynucleotides. J Leukoc Biol 2002;72:1154-63.
36. Borchers A, Ansari AA, Hsu T, Kono DH, Gershwin ME. The pathogenesis of autoimmunity in New Zealand mice. Semin Arthritis Rheum 2000;29:385-99.
37. Isenberg DA, Ravirajan CT, Rahman A, Kalsi J. The role of antibodies to DNA in systemic lupus erythematosus: a review and introduction to an international workshop on DNA antibodies held in London, May 1996. Lupus 1997;6:294-304.
38. Termaat RM, Assmann KJ, Dijkman HB, van Gompel F, Smeenk RJ, Berden JH. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int 1992;42:1363-71.
39. Singh RR, Kumar V, Ebling FM, Southwood S, Sette A, Sercarz EE, et al. T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J Exp Med 1995;181:2017-27.
40. Zeng D, Lee MK, Tung J, Brendolan A, Strober S. Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J Immunol 2000;164:5000-4.
41. 1 lupus-like nephritis with monoclonal antibody to γ interferon. J Exp Med 1987;166:798-803.
42. Boumpas DT, Austin HA III, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992;340:741-5.
43. Schiffer LE, Hussain N, Wang X, Huang W, Sinha J, Ramanujam M, et al. Lowering anti-dsDNA antibodies: what's new? Lupus 2002;11:885-94.
44. Madaio MP. The role of autoantibodies in the pathogenesis of lupus nephritis. Semin Nephrol 1999;19:48-56.
45. Ehrenstein MR, Katz DR, Griffiths MH, Papadaki L, Winkler TH, Kalden JR, et al. Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int 1995;48:705-11.
46. Viallard JF, Pellegrin JL, Ranchin V, Schaeverbeke T, Dehais J, Longy-Boursier M, et al. Th1 (IL-2, interferon-γ (IFN-γ)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1999;115:189-95.
47. Elenitsas R, Abell E, Lee YY, Huang J, Deng JS. Comparison of IgG subclass autoantibodies in patients with systemic lupus erythematosus and subacute cutaneous lupus erythematosus. J Dermatol Sci 1990;1:207-15.
48. Graninger WB, Hassfeld W, Pesau BB, Machold KP. Induction of SLE by IFN-γ in a patient with rheumatoid arthritis. J Rheumatol 1991;18:1621-2.
49. Shirota H, Gursel M, Klinman DM. Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFNγ- and IL-12-mediated signaling. J Immunol 2004;173:5002-7.